首页> 外文期刊>Genetics in medicine >Ashkenazi Jewish genomic variants: integrating data from the Israeli National Genetic Database and gnomAD.
【24h】

Ashkenazi Jewish genomic variants: integrating data from the Israeli National Genetic Database and gnomAD.

机译:Ashkenazi犹太基因组变体:将数据从以色列国家遗传数据库和Gnomad集成。

获取原文
获取原文并翻译 | 示例
           

摘要

The aim of the study was to compare the data for mutations related to clinical disorders reported among Ashkenazi Jewish patients in the Israeli National Genetic Database (INGD) with variants included in the Genome Aggregation Database (gnomAD). We extracted data for mutations claimed to cause disorders reported among Ashkenazi Jews from the INGD and searched gnomAD for each of them. We compared the allele frequency of each variant in Ashkenazi Jews with that of other delineated populations. Of the 58 INGD-reported mutations related to autosomal-dominant disorders, 19 were present in gnomAD (32.8%). Of the 309 mutations related to autosomal-recessive disorders, 240 (77.7%) were variants found in gnomAD. Of these variants, 202 (84.2%) were documented among one or more Ashkenazi individuals. At this point in the INGD, there are 168 Ashkenazi assumed founder mutations in 128 different genes corresponding to 111 autosomal-recessive disorders. Integration of information on mutations among Ashkenazi Jews extracted from the INGD with their population frequency recorded in gnomAD is important for effective straightforward molecular diagnosis as well as for targeted carrier screening either for reproductive decision-making or for implementation of disease-modifying behavior.
机译:该研究的目的是比较与以色列国家遗传数据库(INGD)中的Ashkenazi犹太患者中报告的临床疾病相关的突变数据与基因组聚合数据库(GNOMAD)中包含的变异。我们提取了声称的突变数据,导致来自INGD的Ashkenazi犹太人的疾病并为每个人搜索Gnomad。我们将每种变种的等位基因频率与其他划定的人群的犹太人的等位基因频率进行了比较。在与常染色体显性障碍有关的58个报告的突变中,19例存在于Gnomad(32.8%)。在与常染色体隐性疾病相关的309个突变中,240(77.7%)是在GNOMAD中发现的变体。在这些变体中,在一个或多个Ashkenazi个体中记录了202名(84.2%)。此时在INGD中,有168个Ashkenazi在128个不同基因中具有对应于111个常染色体隐性疾病的不同基因中的创始人突变。从INGD中提取的Ashkenazi犹太人的突变的整合与在GNOMAD中记录的人口频率对于有效直接的分子诊断以及针对生殖决策或实施疾病改性行为的靶向载体筛选是重要的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号